Royalty Pharma plc Public Float
Royalty Pharma plc (RPRX) had Public Float of $16.70 billion as of 2025-06-30, per its 10-K filed 2026-02-11.
Financial Statements › Notes
dei:EntityPublicFloat · last filed 2026-02-11
- 2025-06-30: Entity Public Float $16.70B.
- 2024-06-30: Entity Public Float $13.10B.
- 2023-06-30: Entity Public Float $13.70B.
- 2022-06-30: Entity Public Float $18.50B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $16.70B 10-K · filed 2026-02-11 |
| 2024-06-30 | $13.10B 10-K · filed 2025-02-12 |
| 2023-06-30 | $13.70B 10-K · filed 2024-02-15 |
| 2022-06-30 | $18.50B 10-K · filed 2023-02-15 |
| 2021-06-30 | $16.60B 10-K · filed 2022-02-15 |
| 2020-06-30 | $4.20B 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |